Lars Ulrik Fokdal

4PUBLICATIONS
35CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 11, 2026
Real-world outcomes of pembrolizumab in advanced anal cancer: a nationwide Danish anal Cancer Group report.

|May 08, 2025
Risk factors for rectal bleeding in prostate cancer after radiotherapy with a validation of current rectal dose constraints.

Ellen Lund Schaldemose, Christine Vestergaard Madsen, Ahmed Hussein Zedan

|Nov 26, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer.

Maj K Kjeldsen, Morten Jørgensen, Dina Sofie B Grønseth

|Aug 08, 2024
Electron beam radiotherapy for the management of squamous cell carcinoma of the anal margin.

Lars Fokdal, Bjarke Mortensen, Lars Henrik Jensen

Pageof 1

Frequent Collaborators

1 joint publications

Lars Henrik Jensen

1 joint publications

Mette Møller Sørensen

1 joint publications

Birgitte Mayland Havelund

1 joint publications

Maj K Kjeldsen